LGALS3 and Cirrhosis: These findings suggest that treatment with complex carbohydrate drugs that bind galectin-3 may represent a therapeutic approach that may be useful in the therapy of advanced fibrosis and cirrhosis in humans, especially as they appear to be extremely well tolerated.